Not quite right. It would have cost me to continue to hold and to lose it all. Now I can only miss out on possible gains in the, at this stage, unlikely event the sp would go up.
Have switched to better opportunities and traded well. That way, even 10c tomorrow at the open wouldn't actually mean less profits.
You and Sera on the other hand have to manage a much higher risk And the way you and Sera aggressively attack anyone having a different opinion shows how insecure you guys actually feel about your IMU investment. You have to tell yourself over and over again that one day the windfall will happen. Good luck, you 2 will need heaps of that here at IMU.
I once thought the same way like you but after watching LC and PH crashing CHM to the brink of extinction and continuing the exact way here the writing was and still is on the wall.
Acer-Cell had great Ph1 data and yet not one of the big guys, not even Novartis that financed that, wanted it. Still, now with similar data so far Ph1b, nobody wants it. That's a fact and should raise concerns.
First IMU did CF33 dose escalation to find out the limit, ok, makes sense. Then IMU said, now we stop, we found it as higher doses didn't show better results.Ok. But now they escalate again. Apart of the 2 bile duct cases- no word at all. We are left to conclude and look at the sp what big pharma and the market think. CF33 is not doing what was expected to the other cancer types.
Anyone who blindly ignores the warning signs shouldn't be surprised when soon the house of cards collapses.
Time will tell.
IMU Price at posting:
3.9¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)